Aortic regurgitation

Czech version

Authors: P. Gregor; H. Línková
Authors‘ workplace: Kardiocentrum III. interní - kardiologická klinika 3. lékařské fakulty UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Petr Widimský, DrSc., FESC
Published in: Vnitř Lék 2013; 59(2): 99-104
Category: Review

Overview

This paper focuses on aortic regurgitation. It covers the findings related to etiopathogenesis, clinical signs, echocardiographic and catheter examination. It analyses the treatment criteria with a focus on cardiac surgery.

Key words:
aortic regurgitation –⁠ aortic valve replacement –⁠ left ventricular volume overload –⁠ echocardiography and aortic regurgitation

Sources

1. Widimský J. Insuficience aorty. In: Kordač V et al. Vnitřní lékařství I. Praha, Avicenum 1988, 560–563.

2. Čerbák R. Nejčastější chlopenní vady: aortální stenóza a mitrální insuficience. Praha, Galén 2007, 188 s.

3. Veselka J, Honěk T, Špatenka J et al. Získané chlopenní vady srdce. Praha, Medcor 2000, 59–84.

4. Gregor P, Widimský P et al. Kardiologie. Praha, Galén 1999, 595 s.

5. Popelová J, Benešová M, Brtko M et al. Doporučené postupy pro diagnostiku a léčbu chlopenních srdečních vad v dospělosti. Guidelines ČKS. CorVasa 2007; 49: K195–K234.

6. Niederle P et al. Echokardiografie. Praha, Triton 2002, 359 s.

7. Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 2006; 48 : 1–148.

8. Bonow RO, Lakatos E, Maron BJ et al. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991; 84 : 1625–1635.

9. Judge DP, Dietz HC. Marfan´s syndrome. Lancet 2005; 366 : 1965–1976.

10. Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (Version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery. Eur Heart J 2012; 33 : 2451–2496.

11. Evangelista A, Roznos P, Symboly A et al. Long-term vasodilator therapy in pacients with severe aortic regurgitation. N Engl J Med 2005; 353 : 1342–1349.

12. Camm AJ, Lüscher TF, Serruys PW. The ESC Textbook of Cardiovascular Medicine. European Society of Cardiology, Blackwell Publishing 2006, 1122 s.

13. Beneš J, Gregor P, Mokráček A Infekční endokarditida: doporučené postupy diagnostiky a léčby, dispenzarizace a profylaxe. Cor Vasa 2007; 49: K157–K171.

14. Kaplan JA, Reich DL, Lake CL et al. Valvular Heart Disease: Replacement and Repair In: Kaplan’s Cardiac Anesthesia. Philadelphia, Saunders Elsevier, 2006, 645–691.

15. Fink MP, Abraham E, Vincent JL et al. Emergent Valvular Disorders In: Textbook of Critical Care. Philadelphia: Saunders Elsevier, 2005, 861–871.

16. Stout KK, Verrier ED. Acute Valvular Regurgitation. Circulation 2009; 119 : 3232–3241.

Labels

Diabetology Endocrinology Internal medicine

Current trends in treatment and follow-up of patients with differentiated thyroid carcinoma – experience with the use of recombinant human thyrotropin

Practice guideline and trends for immunosuppressive treatment of glomerulonephritides according to KDIGO (Clinical Practice Guideline for Glomerulonephritis)

Syncope as first and only sign of left atrial myxoma

Heart transplantation and the subsequent treatment of AL amyloidosis

Opinion of the Czech Atherosclerosis Society‘s committee (CSAT) on the ESC/EAS guidlines related to the diagnostics and treatment of dyslipidemias issued in 2011

Ischemic peripheral arterial disease and recurrent iliofemoral venous thrombosis in a 24-year-old man with antiphospholipid syndrome

Article was published in

Internal Medicine

2013 Issue 2